On Monday, Cognition Therapeutics Inc (NASDAQ: CGTX) opened higher 7.03% from the last session, before settling in for the closing price of $0.65. Price fluctuations for CGTX have ranged from $0.22 to $2.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -16.44% over the past five years. Company’s average yearly earnings per share was noted 52.62% at the time writing. With a float of $50.00 million, this company’s outstanding shares have now reached $61.97 million.
Let’s look at the performance matrix of the company that is accounted for 28 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cognition Therapeutics Inc (CGTX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cognition Therapeutics Inc is 19.35%, while institutional ownership is 9.13%. The most recent insider transaction that took place on Jan 31 ’25, was worth 30,001. In this transaction CEO & President of this company bought 38,851 shares at a rate of $0.77, taking the stock ownership to the 38,851 shares.
Cognition Therapeutics Inc (CGTX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 52.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.88% during the next five years compared to -16.44% drop over the previous five years of trading.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Check out the current performance indicators for Cognition Therapeutics Inc (CGTX). In the past quarter, the stock posted a quick ratio of 2.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.73, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
Cognition Therapeutics Inc (NASDAQ: CGTX) saw its 5-day average volume 7.23 million, a positive change from its year-to-date volume of 3.96 million. As of the previous 9 days, the stock’s Stochastic %D was 34.04%.
During the past 100 days, Cognition Therapeutics Inc’s (CGTX) raw stochastic average was set at 58.42%, which indicates a significant increase from 54.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1000 in the past 14 days, which was higher than the 0.0455 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3735, while its 200-day Moving Average is $0.4784.
